These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10652627)

  • 1. Physicochemical conditions affecting the formation/stability of serum complexes and the determination of prostate-specific antigen (PSA).
    Kioukia-Fougia N; Christofidis I; Strantzalis N
    Anticancer Res; 1999; 19(4B):3315-20. PubMed ID: 10652627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and determination of the complex between prostate-specific antigen and alpha 1-protease inhibitor in benign and malignant prostatic diseases.
    Zhang WM; Finne P; Leinonen J; Stenman UH
    Scand J Clin Lab Invest Suppl; 2000; 233():51-8. PubMed ID: 11317942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concentrations of free form and complex form of prostate-specific antigen in serum of alpha 2 macroglobulin deficient patients with prostatic carcinoma].
    Kanoh Y; Jimbo S; Shibuya M; Matsuyama N; Mashiko T; Tanaka T; Egawa S; Ohtani H
    Rinsho Byori; 1998 Sep; 46(9):923-9. PubMed ID: 9800478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
    Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
    J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to alpha 1-antichymotrypsin.
    Lilja H
    Urol Clin North Am; 1993 Nov; 20(4):681-6. PubMed ID: 7505976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
    Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
    Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of the pH- and the temperature-dependent deviations of the free to total PSA (prostate specific antigen) ratios for clinical predictability of prostate cancer and benign prostate hyperplasia.
    Chen KC; Peng CH; Wang HE; Peng CC; Peng RY
    Bull Math Biol; 2004 May; 66(3):423-45. PubMed ID: 15006442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex formation between PSA isoenzymes and protease inhibitors.
    Leinonen J; Zhang WM; Stenman UH
    J Urol; 1996 Mar; 155(3):1099-103. PubMed ID: 8583572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
    Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y; Okamura K; Takamura S; Okamoto N; Narishima M; Yoshino Y; Hattori R; Ono Y; Ohshima S; Nagasaka T
    Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex formation between human prostate-specific antigen and protease inhibitors in mouse plasma.
    Hekim C; Riipi T; Zhu L; Laakkonen P; Stenman UH; Koistinen H
    Prostate; 2010 Apr; 70(5):482-90. PubMed ID: 19937596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen-alpha 2-macroglobulin complexes in prostate cancer patient sera.
    Heeb MJ; España F; Gittes RF; Griffin JH
    Biochem Mol Biol Int; 1995 Nov; 37(5):917-23. PubMed ID: 8624498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Hammerer P; Graefen M; Semjonow A; Stieber P; Ossendorf M; Luboldt HJ; Brux B; Stephan C; Schnorr D; Loening SA
    Prostate; 2001 May; 47(2):77-84. PubMed ID: 11340629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
    Finne P; Zhang WM; Auvinen A; Leinonen J; Määttänen L; Rannikko S; Tammela TL; Stenman UH
    J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M; Ohyama C; Wada Y
    Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum total and free prostate-specific antigen for breast cancer diagnosis in women.
    Black MH; Giai M; Ponzone R; Sismondi P; Yu H; Diamandis EP
    Clin Cancer Res; 2000 Feb; 6(2):467-73. PubMed ID: 10690525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
    Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
    J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium.
    Ornstein DK; Englert C; Gillespie JW; Paweletz CP; Linehan WM; Emmert-Buck MR; Petricoin EF
    Clin Cancer Res; 2000 Feb; 6(2):353-6. PubMed ID: 10690510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.